Alchemab has developed a highly differentiated platform which enables the identification of novel drug targets and therapeutics by analysis of patient antibody repertoires. The platform uses well-defined patient samples, deep B cell sequencing, and computational analysis to identify convergent protective antibody responses among individuals that are susceptible but resilient to specific diseases.
Alchemab is building a broad pipeline of protective therapeutics for hard-to-treat diseases, with an initial focus on neurodegenerative conditions and oncology. The highly specialized patient samples that power Alchemab's platform are made available through valued partnerships and collaborations with patient representative groups, biobanks, industry partners, and academic institutions.
At the platform's core is one of the largest and most clinically meaningful antibody datasets in existence: half a billion antibody sequences drawn from thousands of patients and growing. The depth and breadth of proprietary data has enabled Alchemab to develop AntiBERTa and FAbCon, two of the leading foundation models for antibody sequences. These assets - unique data at scale, combined with state-of-the-art models - create the foundation for Alchemab's drug discovery pipeline.
The RoleReporting in to the ML Director, this individual contributor role has real influence over technical direction and will operate and thrive at the interface of research and impact. The Principal Deep Learning (DP) Researcher will develop deep learning models and apply them across Alchemab's antibody discovery pipeline - from representation learning on B-cell receptor repertoires and antigen binding prediction, to generative models for sequence optimisation. You will work closely with software developers, computational biologists, experimental scientists, and antibody engineers to turn Alchemab's high-dimensional data into actionable model outputs and testable hypotheses, while helping set the ML strategy and supporting the development of colleagues across the organisation. Ultimately, the purpose of this role is to deliver innovative, production ready deep learning solutions that materially advance Alchemab's antibody discovery and optimisation platform.
ResponsibilitiesEssential
NOTE: This job description is not intended to be all inclusive. Employees may perform other related duties as negotiated to meet the ongoing needs of the organisation.